Goldman Sachs Group Inc Castle Biosciences Inc Transaction History

Goldman Sachs Group Inc

$706 Billion
Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 273,443 shares of CSTL stock, worth $6.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

273,443

Previous 175,325 55.96%

Holding current value

$6.16 Million

Previous $3.51 Million 59.06%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$15.8 - $21.98 $1.55 Million - $2.16 Million	98,118 Added 55.96%	273,443 $5.58 Million
Q1 2025 May 09, 2025	SELL	$18.76 - $32.72 $4.83 Million - $8.42 Million	-257,425 Reduced 59.49%	175,325 $3.51 Million
Q4 2024 Feb 11, 2025	BUY	$26.52 - $34.67 $5.04 Million - $6.59 Million	189,950 Added 78.23%	432,750 $11.5 Million
Q3 2024 Nov 14, 2024	BUY	$17.4 - $31.47 $446,536 - $807,614	25,663 Added 11.82%	242,800 $6.92 Million
Q2 2024 Aug 13, 2024	BUY	$18.84 - $24.94 $1.74 Million - $2.31 Million	92,465 Added 74.17%	217,137 $4.73 Million
Q1 2024 May 15, 2024	BUY	$18.06 - $25.3 $799,750 - $1.12 Million	44,283 Added 55.09%	124,672 $2.76 Million
Q4 2023 Feb 13, 2024	SELL	$12.19 - $22.43 $869,902 - $1.6 Million	-71,362 Reduced 47.03%	80,389 $1.73 Million
Q3 2023 May 14, 2024	BUY	$13.28 - $20.3 $947,687 - $1.45 Million	71,362 Added 88.77%	151,751 $2.56 Million
Q3 2023 Nov 14, 2023	BUY	$13.28 - $20.3 $929,998 - $1.42 Million	70,030 Added 85.69%	151,751 $2.56 Million
Q2 2023 May 14, 2024	SELL	$11.66 - $26.0 $655,210 - $1.46 Million	-56,193 Reduced 40.74%	81,721 $1.12 Million
Q2 2023 Aug 14, 2023	SELL	$11.66 - $26.0 $655,210 - $1.46 Million	-56,193 Reduced 40.74%	81,721 $1.12 Million
Q1 2023 May 14, 2024	SELL	$19.47 - $28.49 $2.12 Million - $3.1 Million	-108,942 Reduced 44.13%	137,914 $3.13 Million
Q1 2023 May 11, 2023	SELL	$19.47 - $28.49 $2.12 Million - $3.1 Million	-108,942 Reduced 44.13%	137,914 $3.13 Million
Q4 2022 May 14, 2024	BUY	$18.08 - $30.0 $1.16 Million - $1.93 Million	64,184 Added 35.14%	246,856 $5.81 Million
Q4 2022 Feb 13, 2023	BUY	$18.08 - $30.0 $1.16 Million - $1.93 Million	64,184 Added 35.14%	246,856 $5.81 Million
Q3 2022 May 14, 2024	BUY	$22.51 - $34.32 $1.42 Million - $2.16 Million	62,987 Added 52.63%	182,672 $4.76 Million
Q3 2022 Nov 10, 2022	BUY	$22.51 - $34.32 $1.42 Million - $2.16 Million	62,987 Added 52.63%	182,672 $4.76 Million
Q2 2022 May 14, 2024	BUY	$16.0 - $45.99 $628,736 - $1.81 Million	39,296 Added 48.88%	119,685 $2.63 Million
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $903,408 - $2.6 Million	56,463 Added 89.31%	119,685 $2.63 Million
Q1 2022 May 16, 2022	SELL	$33.17 - $46.98 $271,529 - $384,578	-8,186 Reduced 11.46%	63,222 $2.84 Million
Q4 2021 Feb 14, 2022	SELL	$39.06 - $67.58 $6.1 Million - $10.5 Million	-156,106 Reduced 68.61%	71,408 $3.06 Million
Q3 2021 Nov 10, 2021	BUY	$60.13 - $77.6 $13.7 Million - $17.7 Million	227,514 New	227,514 $15.1 Million

Others Institutions Holding CSTL

# of Institutions

165

Shares Held

27.2M

Call Options Held

Put Options Held

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $592M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Castle Biosciences Inc Transaction History